Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension
Status:
Completed
Trial end date:
2021-06-27
Target enrollment:
Participant gender:
Summary
an open label,balanced,randomized,two-treatment,two-period,two-sequence,single
dose,crossover,oral bioequivalence Study of oseltamivir phosphate for oral suspension in
healthy ,adult,human subjects under fasted/fed conditions.